Harvard Bioscience Sees Q1 Sales $20.000M-$22.000M vs $21.250M Est
Benzinga Newsdesk 7 months ago
NewsGuidance
Harvard Bioscience (NASDAQ:HBIO) sees Q1 sales of $20.000 million-$22.000 million vs $21.250 million analyst estimate.
Harvard Bioscience (NASDAQ:HBIO) sees Q1 sales of $20.000 million-$22.000 million vs $21.250 million analyst estimate.